Skip to main content

Find Clinical Trials

Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,644 public trials 304 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

NCT00355524

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Los Angeles, California, United States

Washington D.C., District of Columbia, United States

Chicago, Illinois, United States

Boston, Massachusetts, United States

View all 22 locations

View Trial Details

Completed

Enhancing Oral Health Care Use by HIV Positive Individuals

NCT00444977

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Completed

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

NCT00672932

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Ucsf Ccrc, Sfgh San Francisco, California, United States

View Trial Details

Completed

A Prospective Observational Study of the Performance of Zarin in Kenya

NCT01334190

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +17 more
Locations: FHI Nairobi, Nairobi County, Kenya

View Trial Details

Completed

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

NCT01751555

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: National Center for AIDS/STD Control and Prevention, China CDC Beijing, Beijing Municipality, China

View Trial Details

Completed

A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs

NCT00183456

Conditions: Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations: The Lighthouse Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

NCT01391013

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

NCT00158821

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

NCT00128830

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

NCT00152061

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Santa Clara Medical Center, PACE Clinic San Jose, California, United States

View Trial Details